Commentary: Hyperlactatemia after cardiac surgery: Yes we know it is bad but can we reliably prevent and treat it?
نویسندگان
چکیده
منابع مشابه
What Do We Know, How Do We Know It, and How Can We Best Apply It?
Adequate Nutrition May get You Home: Effect of Caloric/Protein Deficits on the Discharge Destination of Critically Ill Surgical Patients 37 D. Dante Yeh, MD; Eva Fuentes, MD; Sadeq A. Quraishi, MD, MHA, MMScH; Catrina Cropano, MSc; Haytham Kaafarani, MD, MPH; Jarone Lee, MD, MPH; David R. King, MD; Marc DeMoya, MD; Peter Fagenholz, MD; Kathryn Butler, MD; Yuchiao Chang, PhD; and George Velmahos...
متن کاملLife, but not as we know it.
Living systems are perhaps the most fascinating examples of chemistry in action. Molecules assemble into biomachinery that can carry out complex tasks, making life possible. But how did it all begin? This question can be tackled from a geological perspective by surveying the possible conditions under which key biomolecules might have emerged on early Earth. Alternatively, a systems-biology appr...
متن کاملLife, but not as we know it
species of chameleon, Furcifer labordi, in Madagascar that spends most of its life as an egg. in Madagascar and the American Museum of Natural History in New York, have found a chameleon with a remarkable lifestyle and report the results in the latest issue of the Proceedings of the National Academy of Sciences (published online). Although there are almost limitless theoretical combinations of ...
متن کاملGlycemic variability: should we and can we prevent it?
Diabetes is characterized by glycemic disorders that include both sustained chronic hyperglycemia and acute glucose fluctuations. There is now cogent evidence for the deleterious effects of sustained chronic hyperglycemia that results in excessive protein glycation and generation of oxidative stress. The role of glucose variability from peaks to nadirs is less documented, but there are many rea...
متن کاملChemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?
BACKGROUND Twenty percent of all newly diagnosed patients with small-cell lung cancer (SCLC) are >75 years. Elderly patients may show more toxicity due to co-morbidity. We evaluated motives for adherence to treatment guidelines, completion of treatment and toxicity. PATIENTS AND METHODS Population-based data from patients aged ≥75 years and diagnosed with SCLC in 1997-2004 in The Netherlands ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JTCVS Techniques
سال: 2020
ISSN: 2666-2507
DOI: 10.1016/j.xjtc.2020.03.035